Swiss Innovation Challenge – Digital kick-off!

2020 Swiss Innovation Challenge – the traditional networking kick-off event for the SIC was held virtually due to COVID-19 crisis on April 2, 2020! Numerous entrepreneurs from Switzerland and other European countries attended the online kick-off for this years challenge. 100 start-ups from all categories will be admitted to the first pitch, but only 50 […]

Congratulations to our portfolio company Inura Medical AG

Inura Medical AG is admitted to participate at the 2020 >>venture>> competition! Inura Medical AG is a Swiss start-up company focused on the development of re-purposed urological products that combine a medical technology consisting of an urethral suppository and a pharmaceutical agent. Its first product offers a rescue therapy to two highly prevalent and disabling […]

Scailyte announces its new advisory board composed of world leading clinicians and scientists

Scailyte™ is an ETH Zürich Spin-off and Top100 Swiss Startup applying artificial intelligence to discover novel and ultra-sensitive biomarkers from single-cell data.Over the past 3 years, we have established ScaiVision™, a proprietary data analytics platform for clinical research, which enables us to achieve groundbreaking discoveries in multiple disease areas. We have validated our approach by […]

“Spread the App, not the Virus”

How geoHealthApp can help stop the spread of COVID-19 Friday 27th of March 2020 – GeoHealthApp GmbH, today launched a Betaversion in Germany, Switzerland, Austria, UK and USA that has the potential to help stop the spread of COVID-19! How does it work? People first install the app, and the phone starts recording their location […]

HEMEX Pitch Series

Swiss startup Scailyte CEO Peter Nestorov presenting at Hemex pitch event

At HEMEX, we regularly organize invitation-only pitch days, where selected startups get the opportunity to pitch in front of potential investors. The focus of our last 2019 pitch session was on startups seeking to revolutionize cancer diagnosis and treatment. Thank you Christina Vallgren, Marcus Palm, Martin Stauber, Seline Eisenring, Michael Krauthammer and Peter Nestorov for […]